Impact of different sequential triple oral combination therapies based selexipag on outcomes in pulmonary arterial hypertension.
Hu X, Yuan P, Chen J, Wang S, Zhao H, Wei Y, Fu J, Chen F, Ruan H, Zhang W, Zhou Y, Wang Q, Xu X, Feng K, Guo J, Gong S, Zhang R, Zhao Q, Wang L.
Hu X, et al. Among authors: feng k.
Clin Cardiol. 2024 Feb;47(2):e24245. doi: 10.1002/clc.24245.
Clin Cardiol. 2024.
PMID: 38402556
Free PMC article.